STAT+: Tracking the FDA expert review of Replimune’s melanoma treatment

STAT is live-blogging a meeting of FDA experts to review Replimune’s experimental melanoma drug, RP1.

CryptoAlerta — análise de criptomoedas e mercado em tempo real